@belpalacio.bsky.social
Reposted
Excited that our preprint is out! 💫 We report #WIN332, the first engineered HIV-1 Env immunogen rationally designed to elicit N332-and N334-glycan independent V3-glycan antibodies.
More ⬇️
www.biorxiv.org/content/10.1...
More ⬇️
www.biorxiv.org/content/10.1...
Rapid elicitation of a new class of neutralizing N332-glycan independent V3-glycan antibodies against HIV-1 in nonhuman primates.
Sequential immunization is a promising approach to elicit broadly neutralizing antibodies (bNAbs) against the HIV-1 Envelope (Env). However, available protocols are inefficient and involve multiple im...
www.biorxiv.org
September 10, 2025 at 5:13 PM
Excited that our preprint is out! 💫 We report #WIN332, the first engineered HIV-1 Env immunogen rationally designed to elicit N332-and N334-glycan independent V3-glycan antibodies.
More ⬇️
www.biorxiv.org/content/10.1...
More ⬇️
www.biorxiv.org/content/10.1...